RiceBran Technologies RIBT Income Statement

Ricebran technologies (RIBT)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenues
25,679	23,713	22,432	20,595	17,574	14,762	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of goods sold
27,288	24,574	22,081	19,131	15,203	11,780	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenues, net
-	-	-	-	-	-	-	-	-	-	-	-	6,546	12,982	26,448	32,116	40,288	39,896	40,651	42,145	42,083	40,108	37,667	35,981	34,026	35,051	35,739	36,363	36,686	37,723	37,208	37,264	38,055	36,957	36,958	35,054	0	0	0
Cost of goods sold
-	-	-	-	-	-	-	-	-	-	-	-	4,469	9,855	19,870	24,296	31,035	31,826	34,411	36,997	37,974	35,639	33,161	31,670	29,633	31,106	32,033	31,551	31,389	31,651	30,949	30,982	30,949	29,386	28,132	26,655	0	0	0
Gross profit (loss)
-1,609	-861	351	1,464	2,371	2,982	3,037	3,423	3,558	3,791	2,398	2,073	2,077	3,127	6,578	7,820	9,253	8,070	6,240	5,148	4,109	4,469	4,506	4,311	4,393	3,945	3,706	4,812	5,297	6,072	6,259	6,282	7,106	7,571	8,826	8,399	0	0	0
Selling, general and administrative expenses
12,905	13,696	13,690	12,274	11,682	11,194	10,562	10,638	10,475	9,888	9,617	10,262	11,271	12,384	12,946	12,783	12,459	12,567	13,426	14,463	14,526	14,354	14,636	13,754	12,599	12,366	12,597	12,329	13,127	13,690	13,033	13,903	14,609	14,441	14,904	14,780	0	0	0
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,622	1,779	1,967	2,236	2,566	2,879	2,570	2,177	1,736	1,249	0	0	0	-	-	-	-	-	-	-	-	-	-
Goodwill impairment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Professional fees
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,157	2,309	2,591	2,922	2,786	2,775	0	0	0
Impairment of property
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	300	300	300	1,369	1,069	1,069	1,069	0	-	0	0	-	0	0
Recoveries from former customers
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,800	-800	-800	0	0	0
Loss on disposal of property, plant and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Provision for doubtful accounts
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Total operating expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14,081	14,346	15,393	16,699	17,092	17,233	17,206	15,931	14,335	13,915	12,495	12,291	14,356	14,759	16,851	17,873	17,792	17,155	17,430	18,372	0	0	0
Operating loss
-14,514	-14,557	-13,339	-10,810	-9,311	-8,212	-7,525	-7,215	-6,917	-6,097	-6,871	-7,841	-8,846	-9,257	-7,135	-6,156	-4,828	-6,276	-9,153	-11,551	-12,983	-12,764	-12,700	-11,620	-9,942	-9,970	-8,789	-7,479	-9,059	-8,687	-10,592	-11,591	-10,686	-9,584	-8,604	-9,973	0	0	0
Interest income
61	50	42	23	0	-	0	0	-	-	-	-	-	-	-	-	91	107	106	146	149	115	135	120	114	109	82	37	37	74	87	109	160	126	131	110	0	0	0
Other income (expense):
Interest expense - accreted on debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense - accreted on debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense - accreted on debt converted to equity
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-
Interest expense - other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,854	2,646	3,083	3,581	0	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-
Interest expense
133	96	47	40	23	12	12	96	569	1,623	0	0	0	-	0	0	-	-	-	-	-	-	-	-	0	-	-	-	2,137	1,926	1,952	1,756	1,793	1,763	1,530	1,528	0	0	0
Other expense
60	16	5	16	13	25	-6	95	95	182	148	35	35	0	0	0	0	-	302	447	476	599	382	334	446	373	561	468	268	237	190	155	533	464	460	436	0	0	0
Yield payable to holders of noncontrolling interest in Nutra SA
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-
Change in fair value of derivative warrant liabilities
-	-	-	-	-	-	-	-	-	670	2,119	3,598	1,913	1,625	104	-408	1,639	1,001	1,681	1,076	-3,094	-1,209	-790	-263	4,567	-1,029	-506	2,420	4,244	5,420	0	0	0	-	-	-	-	-	-
Loss on acquisition of controlling interest in Rice Rx
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Change in fair value of derivative warrant and conversion liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,025	-399	0	0	0
Loss on acquisition of additional interests in Rice Rx
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Loss on extinguishment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0
Financing expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,072	2,072	2,072	1,686	564	564	1,204	660	2,184	2,184	1,544	1,524	0	0	0	0	-	-
Foreign currency exchange, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-85	-370	-386	-496	-468	-174	-162	-17	-615	-440	-390	-123	-161	-617	-404	-934	-349	-99	-291	0	0	0	-
Loss on extinguishment of debt
-	-	-	-	-	-	-	-	-	-8,290	-8,290	-1,680	-1,680	0	0	0	0	-	0	0	-	-	0	0	-	-2,891	-526	-2,481	-1,987	-4,941	0	0	0	-	-	-	-	-	-
Loss on conversion of preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on resolution of Irgovel purchase litigation
-	-	-	-	-	-	-	-	-	-	-	-	-	1,598	1,598	1,598	1,598	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other income
889	884	917	67	0	-	0	0	-	307	0	0	0	-	0	0	-	-	119	127	123	12	46	58	56	13	29	25	26	27	-156	-128	178	232	467	528	0	0	0
Total other income
-	-	987	157	-	156	29	-6,974	-7,401	-9,118	-7,994	-83	-1,780	1,303	-933	-2,109	-2,410	-4,476	-3,814	-4,908	-15,567	-15,167	-17,334	-16,658	-5,362	-9,109	-5,796	-4,568	-906	-4,384	-6,175	-6,415	-6,301	-1,636	-658	-1,705	0	0	0
Professional fees
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Loss before income taxes
-13,757	-13,735	-12,352	-10,653	-9,154	-8,056	-7,496	-14,189	-14,318	-15,215	-14,865	-7,924	-10,626	-7,954	-8,068	-8,265	-7,238	-10,752	-12,967	-16,459	-28,550	-27,931	-30,034	-28,278	-15,304	-19,079	-14,585	-12,047	-9,965	-13,071	-16,767	-18,006	-16,987	-11,220	-9,373	-12,188	0	0	0
Income tax benefit
0	0	45	45	45	45	3	-4,118	-4,633	-5,030	-5,905	-2,221	-2,221	-1,824	-1,110	-679	-170	-176	-585	-718	-1,062	-1,304	-459	-956	-1,177	-1,439	-2,547	-2,105	-1,903	-1,935	-1,198	-1,248	-827	-345	-395	-451	0	0	0
Loss from continuing operations
-13,757	-13,735	-12,397	-10,698	-9,199	-8,101	-7,499	-10,071	-9,685	-10,185	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from discontinued operations
0	-216	-216	-216	-216	0	-2,839	3,867	4,171	3,983	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-13,757	-13,951	-12,613	-10,914	-9,415	-8,101	-10,338	-6,204	-5,514	-6,202	-3,010	-7,067	-13,713	-11,250	-11,206	-11,226	-7,068	-10,576	-12,382	-15,741	-27,488	-26,627	-29,575	-27,322	-14,127	-17,640	-12,038	-9,942	-8,062	-11,136	-15,569	-16,758	-16,160	-10,875	-8,978	-11,737	0	0	0
Less - Net loss attributable to noncontrolling interest in discontinued operations
-	-	-	-	-	-	-	-	-	-1,671	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss attributable to noncontrolling interest in Nutra SA
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,102	-2,308	-2,922	-3,109	-3,322	-3,598	-3,784	-3,156	-3,054	-2,619	-2,076	-1,683	-1,569	-1,627	-1,645	-1,709	-1,291	-776	-315	-39	0	0	0
Net loss attributable to RiceBran Technologies shareholders
-	-	-	-	-	-	-	-	-	-4,531	-1,347	-5,726	-11,112	-8,530	-8,604	-8,048	-4,966	-8,268	-9,460	-12,632	-24,166	-23,029	-25,791	-24,166	-11,073	-15,021	-9,962	-8,259	-6,493	-9,509	-13,924	-15,049	-14,869	-10,099	-8,663	-11,698	0	0	0
Less - Dividends on preferred stock, beneficial conversion feature
-	-	-	-	-	-	-	-	-	778	778	778	778	551	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividends on preferred stock-beneficial conversion feature
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss attributable to RiceBran Technologies common shareholders
-	-	-	-	-	-	-	-	-	-5,309	-2,125	-6,504	-11,890	-9,081	-9,155	-8,599	-5,517	-8,268	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic loss per common share:
Continuing operations (in dollars per share)
-0.08	-0.11	-0.10	-0.11	-0.10	-0.08	-0.07	-0.11	-0.11	-0.03	-0.38	-0.18	-0.33	-	-0.10	-0.48	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Discontinued operations (in dollars per share)
0.00	0.00	0.00	0.00	-0.01	0.00	0.00	0.00	0.00	-0.28	0.68	0.06	0.01	-	-0.01	-0.24	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic loss per common share (in dollars per share)
-0.08	-0.11	-0.10	-0.11	-0.11	-0.08	-0.07	-0.11	-0.11	-0.31	0.30	-0.12	-0.32	-0.11	-0.11	-0.72	-0.03	-0.13	-0.06	-0.38	-0.33	0.65	-0.47	-3.52	-0.62	-3.72	-1.83	-1.83	-5.57	-9.25	0.00	0.00	-0.04	-0.02	-0.01	0.00	-0.02	-0.02	-0.02
Diluted loss per common share:
Continuing operations (in dollars per share)
-0.08	-0.11	-0.10	-0.11	-0.10	-0.08	-0.07	-0.11	-0.11	-0.03	-0.38	-0.18	-0.33	-	-0.10	-0.48	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Discontinued operations (in dollars per share)
0.00	0.00	0.00	0.00	-0.01	0.00	0.00	0.00	0.00	-0.28	0.68	0.06	0.01	-	-0.01	-0.24	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted loss per common share (in dollars per share)
-0.08	-0.11	-0.10	-0.11	-0.11	-0.08	-0.07	-0.11	-0.11	-0.31	0.30	-0.12	-0.32	-0.11	-0.11	-0.72	-0.03	-0.13	-0.06	-0.38	-0.33	0.65	-0.47	-3.52	-0.62	-3.72	-1.83	-1.83	-5.57	-9.25	0.00	0.00	-0.04	-0.02	-0.01	0.00	-0.02	-0.02	-0.02
Weighted average number of shares outstanding:
Basic (in shares)
39,963	33,828	33,057	33,204	29,347	26,854	24,092	20,366	17,083	17,113	11,129	9,794	9,657	9,508	9,397	9,231	9,215	9,207	9,222	9,167	9,154	8,030	7,915	4,274	3,017	1,394	1,129	1,073	1,043	-608,050	204,869	204,588	202,686	-198,981,024	199,380,838	198,310	195,358	193	193,028
Diluted (in shares)
39,963	33,828	33,057	33,204	29,347	26,854	24,092	20,366	17,083	17,113	11,129	9,794	9,657	9,508	9,397	9,231	9,215	9,207	9,222	9,167	9,154	8,030	7,915	4,274	3,017	1,394	1,129	1,073	1,043	-608,050	204,869	204,588	202,686	-198,981,024	199,380,838	198,310	195,358	193	193,028